A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells.
about
RNAi screening with shRNAs against histone methylation-related genes reveals determinants of sorafenib sensitivity in hepatocellular carcinoma cellsA computational strategy to select optimized protein targets for drug development toward the control of cancer diseasesNucleophosmin modulates stability, activity, and nucleolar accumulation of base excision repair proteins.Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma.The synergistic effect of resveratrol in combination with cisplatin on apoptosis via modulating autophagy in A549 cellsNPM1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells.Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.Phosphorylation of nucleophosmin at threonine 234/237 is associated with HCC metastasis.iTRAQ-Based Quantitative Proteomic Analysis of Nasopharyngeal Carcinoma.Ribosomal Proteins Control or Bypass p53 during Nucleolar Stress.Functional genomics identified a novel protein tyrosine phosphatase receptor type F-mediated growth inhibition in hepatocarcinogenesis.The Wnt Target Protein Peter Pan Defines a Novel p53-independent Nucleolar Stress-Response Pathway.Downregulation of NPM expression by Her-2 reduces resistance of gastric cancer to oxaliplatin.The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma.Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma.Contribution of nucleophosmin overexpression to multidrug resistance in breast carcinoma.Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis
P2860
Q28383116-C4148B94-F215-47FF-A86B-3E416F99370FQ28543105-78CA2275-36FB-4DED-ABE2-086DAB92E1D4Q30577959-C2251F51-626D-4EB8-9E1A-3DE77D1B2BC1Q34104067-58FADCF2-C21F-4EF3-8D46-1F1734B6961BQ35991555-768119CA-CFAF-452E-B449-FEA40D38E8DAQ36356360-9C6FD559-232E-4ACB-9A8F-4A40185D09D3Q38450711-A522A21C-F22D-4A94-8ACC-FD1858E3084FQ38822052-F1E3BF75-37F2-4937-8446-1D235400085BQ38913291-E0843E0E-00C5-4E74-963F-C05A92AFD158Q39085684-0A5A66DB-EC34-41D6-94D8-EC1B39FCAECBQ39262323-88B147ED-0D15-4EAB-A4FD-48F69410F8A4Q39944723-CDC87054-9649-4F71-AF56-E9F4F023A71CQ42290643-772DF844-03D7-4BE7-8413-4455FE667B6EQ46755879-1148F083-FDFF-4355-8F54-D290044F0E6AQ52571263-B4DD5723-78CC-4EFA-BB5E-4E50F35927B9Q53738419-64D34DF3-AADA-4094-B554-92EC41AB3B71Q58736349-6A34033A-0AF4-4B21-A5C7-B89C6A236A5D
P2860
A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A novel interaction of nucleop ...... ivity in human hepatoma cells.
@en
A novel interaction of nucleop ...... ivity in human hepatoma cells.
@nl
type
label
A novel interaction of nucleop ...... ivity in human hepatoma cells.
@en
A novel interaction of nucleop ...... ivity in human hepatoma cells.
@nl
prefLabel
A novel interaction of nucleop ...... ivity in human hepatoma cells.
@en
A novel interaction of nucleop ...... ivity in human hepatoma cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
A novel interaction of nucleop ...... tivity in human hepatoma cells
@en
P2093
Hsiao-Ling Huang
Kuo-Yang Lin
Li-Ching Fan
Sen-Yung Hsieh
Shao-Jung Lo
Shiu-Fen Huang
Tong-Hong Wang
Tse-Chin Chen
Yow-Fu Tsai
P2860
P304
P356
10.1002/HEP.26209
P407
P577
2013-04-01T00:00:00Z